盘龙药业(002864)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002864 盘龙药业

已收盘 04-28 15:00:00

{"stockData":{"symbol":"002864","market":"SZ","secType":"STK","nameCN":"盘龙药业","latestPrice":29.6,"timestamp":1777359834000,"preClose":30.33,"halted":0,"volume":3418000,"delay":0,"changeRate":-0.0241,"floatShares":73685200,"shares":106000000,"eps":0.8167,"marketStatus":"已收盘","change":-0.73,"latestTime":"04-28 15:00:00","open":30,"high":30.16,"low":29.41,"amount":102000000,"amplitude":0.0247,"askPrice":29.6,"askSize":2,"bidPrice":29.59,"bidSize":5,"shortable":0,"etf":0,"ttmEps":0.8167,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777426200000},"marketStatusCode":5,"adr":0,"adjPreClose":30.33,"symbolType":"stock","openAndCloseTimeList":[[1777339800000,1777347000000],[1777352400000,1777359600000]],"highLimit":33.36,"lowLimit":27.3,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":106280960,"isCdr":false,"pbRate":1.89,"roa":"--","peRate":36.243419,"roe":"1.28%","epsLYR":0.92,"committee":-0.338843,"marketValue":3146000000,"turnoverRate":0.0464,"status":1,"floatMarketCap":2181000000},"requestUrl":"/m/hq/s/002864","defaultTab":"news","newsList":[{"id":"2630039073","title":"盘龙药业（002864）披露2026年一季度报告，4月27日股价上涨0.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630039073","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630039073?lang=zh_cn&edition=full","pubTime":"2026-04-27 22:29","pubTimestamp":1777300174,"startTime":"0","endTime":"0","summary":"截至2026年4月27日收盘，盘龙药业报收于30.33元，较前一交易日上涨0.46%，最新总市值为32.24亿元。该股当日开盘30.24元，最高30.42元，最低29.72元，成交额达7362.07万元，换手率为3.32%。近日，陕西盘龙药业集团股份有限公司披露2026年第一季度报告。报告显示，本报告期营业收入为222,541,696.37元，较上年同期下降11.06%；归属于上市公司股东的净利润为21,760,948.70元，同比下降30.36%；归属于上市公司股东的扣除非经常性损益的净利润为20,014,169.48元，同比下降30.39%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700046763.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629834106","title":"盘龙药业：坚持以高质量经营夯实基本面","url":"https://stock-news.laohu8.com/highlight/detail?id=2629834106","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629834106?lang=zh_cn&edition=full","pubTime":"2026-04-23 20:52","pubTimestamp":1776948728,"startTime":"0","endTime":"0","summary":"证券之星消息，盘龙药业04月22日在投资者关系平台上答复投资者关心的问题。坚持以高质量经营夯实基本面，常态化开展投资者沟通，严格执行持续稳定分红政策，积极传递公司长期价值。公司严格遵守信息披露相关法律法规及监管要求，不存在应披露而未披露的重大事项，所有重大信息均及时、公平、合规履行披露义务。相关项目进展公司将严格按照规定及时公告，请以官方披露信息为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300059146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624571232","title":"盘龙药业：公司高度重视股东回报与价值维护","url":"https://stock-news.laohu8.com/highlight/detail?id=2624571232","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624571232?lang=zh_cn&edition=full","pubTime":"2026-04-02 16:36","pubTimestamp":1775118982,"startTime":"0","endTime":"0","summary":"证券之星消息，盘龙药业(002864)04月02日在投资者关系平台上答复投资者关心的问题。投资者提问：公司股价低迷，10年前差不多就是这价位，跟经营业绩持续增长不匹配，处于低估状态，公司账上现金充足，建议董事会为股东着想，拿出3–4亿元回购注销公司股份？盘龙药业回复：尊敬的投资者您好！感谢您的关注和宝贵建议。公司高度重视股东回报与价值维护，资金统筹安排将兼顾主业经营、研发创新与长期发展，持续夯实内在价值。公司将严格依规履行审议程序及信息披露义务。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200027208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621295086","title":"股市必读：盘龙药业（002864）3月23日收盘跌7.82%，主力净流入734.79万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621295086","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621295086?lang=zh_cn&edition=full","pubTime":"2026-03-24 02:57","pubTimestamp":1774292228,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，盘龙药业报收于31.34元，下跌7.82%，换手率8.07%，成交量5.99万手，成交额1.92亿元。交易信息汇总股价提醒3月23日盘龙药业收盘报31.34元，跌7.82%，当日成交598.54万元。前10个交易日资金流向情况：主力资金累计净流入1130.12万元，股价累计下跌7.5%。资金流向3月23日主力资金净流入734.79万元；游资资金净流出1563.32万元；散户资金净流入828.53万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400002642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619199639","title":"盘龙药业：3月12日董事朱文锋减持股份合计2.25万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2619199639","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619199639?lang=zh_cn&edition=full","pubTime":"2026-03-13 19:01","pubTimestamp":1773399674,"startTime":"0","endTime":"0","summary":"证券之星消息，根据3月13日市场公开信息、上市公司公告及交易所披露数据整理，盘龙药业（002864）最新董监高及相关人员股份变动情况：2026年3月12日公司董事朱文锋共减持公司股份2.25万股，占公司总股本为0.0212%。变动期间公司股价下跌1.91%，3月12日当日收盘报33.3元。盘龙药业近半年内的董监高及核心技术人员增减持详情如下：盘龙药业的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300033464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616346888","title":"盘龙药业最新公告：获得硫酸氨基葡萄糖胶囊药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2616346888","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616346888?lang=zh_cn&edition=full","pubTime":"2026-03-03 18:19","pubTimestamp":1772533197,"startTime":"0","endTime":"0","summary":"盘龙药业公告称，公司收到国家药品监督管理局颁发的硫酸氨基葡萄糖胶囊的《药品注册证书》。根据米内网数据显示，2024年国内城市和县级公立医院、城市和网上药店、城市社区医院和乡镇卫生院的销售金额约33.62亿元人民币。本次获批将进一步丰富公司非处方药管线与骨科慢病产品矩阵，有利于公司拓展院外市场、推进渠道终端下沉，提升品牌在基层及零售终端的影响力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300033639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614703759","title":"股市必读：盘龙药业（002864）2月25日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2614703759","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614703759?lang=zh_cn&edition=full","pubTime":"2026-02-26 01:47","pubTimestamp":1772041632,"startTime":"0","endTime":"0","summary":"截至2026年2月25日收盘，盘龙药业报收于37.61元，下跌0.66%，换手率4.95%，成交量3.67万手，成交额1.38亿元。董秘最新回复投资者： 公司对腰间盘突出，脊椎骨3，4，5节压迫神经，从而导致人体站不直，神经痛，走路难＇痛的问题？公司深耕主业，已形成包括药品研发、生产及销售在内的完整业务体系。相关产品主要依据获批适应症用于相应病症的治疗。当日关注点来自交易信息汇总：2月25日主力资金净流出326.48万元，散户资金净流入262.32万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600000965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609309344","title":"盘龙药业（002864）披露注销部分募集资金账户公告，2月5日股价上涨3.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609309344","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609309344?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:17","pubTimestamp":1770301035,"startTime":"0","endTime":"0","summary":"截至2026年2月5日收盘，盘龙药业报收于36.46元，较前一交易日上涨3.05%，最新总市值为38.75亿元。该股当日开盘35.41元，最高36.9元，最低35.23元，成交额达2.69亿元，换手率为9.99%。近日，陕西盘龙药业集团股份有限公司发布《关于注销部分募集资金账户的公告》。公司称已按规定履行信息披露义务，确保内容真实、准确、完整。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500039520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608316877","title":"盘龙药业（002864）披露董事减持股份预披露公告，2月3日股价上涨0.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608316877","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608316877?lang=zh_cn&edition=full","pubTime":"2026-02-03 22:25","pubTimestamp":1770128723,"startTime":"0","endTime":"0","summary":"截至2026年2月3日收盘，盘龙药业报收于35.35元，较前一交易日上涨0.28%，最新总市值为37.57亿元。近日，盘龙药业发布《关于董事减持股份预披露公告》。其计划在公告披露之日起15个交易日后的3个月内，通过集中竞价方式减持不超过22,500股，占剔除公司已回购股份的总股本比例不超过0.0212%。减持期间为2026年3月5日至2026年6月4日，减持价格将按市场价格确定。本次减持符合其在任职期间的相关承诺，不存在违反承诺的情形。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300043224.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608308852","title":"盘龙药业(002864.SZ)：氟比洛芬贴剂获准开展临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2608308852","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608308852?lang=zh_cn&edition=full","pubTime":"2026-02-02 17:31","pubTimestamp":1770024709,"startTime":"0","endTime":"0","summary":"智通财经APP讯，盘龙药业(002864.SZ)公告，公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，同意氟比洛芬贴剂开展临床试验。相关适应症为下述疾病及症状的镇痛、消炎：骨关节炎、肩关节周围炎、腱炎及腱鞘炎、腱周炎、肱骨外上髁炎(如网球肘等)、肌肉痛、外伤后的肿胀及疼痛。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400599.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606407652","title":"股市必读：盘龙药业（002864）1月26日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2606407652","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606407652?lang=zh_cn&edition=full","pubTime":"2026-01-27 02:09","pubTimestamp":1769450953,"startTime":"0","endTime":"0","summary":"截至2026年1月26日收盘，盘龙药业报收于37.11元，上涨0.0%，换手率8.4%，成交量6.23万手，成交额2.33亿元。公司将严格按照相关法律法规及时履行信息披露义务，敬请关注公司后续公告。来自交易信息汇总：散户资金净流入211.0万元，表明个人投资者今日整体偏向买入。交易信息汇总资金流向1月26日主力资金净流出847.05万元；游资资金净流入636.05万元；散户资金净流入211.0万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700001719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601281678","title":"异动快报：盘龙药业（002864）1月7日10点42分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2601281678","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601281678?lang=zh_cn&edition=full","pubTime":"2026-01-07 10:45","pubTimestamp":1767753917,"startTime":"0","endTime":"0","summary":"证券之星1月7日盘中消息，10点42分盘龙药业触及涨停板。其所属行业中药目前下跌。该股为创新药，医药，肝炎概念概念热股，当日创新药概念上涨1.45%，医药概念上涨0.64%，肝炎概念概念上涨0.02%。1月6日的资金流向数据方面，主力资金净流出32.87万元，占总成交额0.35%，游资资金净流出117.77万元，占总成交额1.24%，散户资金净流入150.63万元，占总成交额1.59%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700010818.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600067020","title":"每周股票复盘：盘龙药业（002864）拟将节余募资5409.79万补流","url":"https://stock-news.laohu8.com/highlight/detail?id=2600067020","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600067020?lang=zh_cn&edition=full","pubTime":"2026-01-03 03:21","pubTimestamp":1767381669,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，盘龙药业报收于30.84元，较上周的31.66元下跌2.59%。本周，盘龙药业12月29日盘中最高价报31.66元。公司公告汇总：公司实际控制人谢晓林及其配偶为5000万元银行贷款无偿提供连带责任担保。公司公告汇总中泰证券对盘龙药业拟将“中药配方颗粒研发及产业化项目”结项，并将节余募集资金5,409.79万元永久补充流动资金事项无异议。公司拟向中国农业银行柞水县支行申请5000万元短期流动资金贷款，年化利率2.10%，期限6个月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300002168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595276052","title":"股市必读：盘龙药业（002864）12月26日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2595276052","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595276052?lang=zh_cn&edition=full","pubTime":"2025-12-29 04:07","pubTimestamp":1766952429,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，盘龙药业报收于31.66元，下跌0.72%，换手率3.26%，成交量2.42万手，成交额7681.33万元。董秘最新回复投资者： 贵公司在AI中药方面有啥具体方案？AI在中药领域的应用仍属前沿探索，公司将持续关注技术发展，稳步推进产学研合作，努力把握行业变革中的发展机遇。当日关注点来自交易信息汇总：12月26日主力资金净流出145.34万元，散户资金净流入402.39万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900001532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594291445","title":"盘龙药业：AI在中药领域的应用仍属前沿探索","url":"https://stock-news.laohu8.com/highlight/detail?id=2594291445","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594291445?lang=zh_cn&edition=full","pubTime":"2025-12-26 21:38","pubTimestamp":1766756280,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：贵公司在AI中药方面有啥具体方案？盘龙药业（002864.SZ）12月26日在投资者互动平台表示，AI在中药领域的应用仍属前沿探索，公司将持续关注技术发展，稳步推进产学研合作，努力把握行业变革中的发展机遇。（文章来源：每日经济新闻）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-26/doc-inhecwez7852023.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-26/doc-inhecwez7852023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594280283","title":"盘龙药业：暂无与拜耳医药等企业项目合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2594280283","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594280283?lang=zh_cn&edition=full","pubTime":"2025-12-25 15:31","pubTimestamp":1766647881,"startTime":"0","endTime":"0","summary":"证券之星消息，盘龙药业(002864)12月25日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司与拜耳医药、罗氏医药、辉瑞制药等企业是否有项目合作？盘龙药业回复：尊敬的投资者您好！公司与拜耳医药、罗氏医药、辉瑞制药等企业暂无项目合作。 感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500016993.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1515","09939","159938","002864","BK0239","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590318473","title":"盘龙药业：抗流感药品已在市场销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2590318473","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590318473?lang=zh_cn&edition=full","pubTime":"2025-12-09 15:15","pubTimestamp":1765264526,"startTime":"0","endTime":"0","summary":"证券之星消息，盘龙药业12月09日在投资者关系平台上答复投资者关心的问题。另外，针对这次流感，公司有没有调整生产计划，或者加大这些药品的生产力度？上述产品均已在市场销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900018265.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588667010","title":"盘龙药业：连续两年获得“上市公司ESG价值传递奖”","url":"https://stock-news.laohu8.com/highlight/detail?id=2588667010","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588667010?lang=zh_cn&edition=full","pubTime":"2025-12-03 18:40","pubTimestamp":1764758401,"startTime":"0","endTime":"0","summary":"在同期举办的“易董ESG价值评级”颁奖典礼上，盘龙药业获得“2025年度上市公司ESG价值传递奖”，这是该企业连续第二年获得此项荣誉。“ESG价值传递奖”是资本市场极具公信力与影响力的重要奖项，旨在表彰在ESG理念传播、社会责任深度践行、投资者关系高效管理等方面表现突出的上市企业。盘龙药业表示，未来公司将进一步深化ESG价值创造与传递工作，通过更扎实的责任实践、更透明的信息披露、更创新的ESG举措，持续提升企业综合竞争力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251203/31842068.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["002864","159717","ESG","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583579029","title":"11月14日盘龙药业（002864）龙虎榜数据：机构净卖出5509.54万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583579029","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583579029?lang=zh_cn&edition=full","pubTime":"2025-11-14 17:33","pubTimestamp":1763112784,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年11月14日公布的交易公开信息显示，盘龙药业因日换手率达到20%的前5只证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2025年11月14日收盘，盘龙药业报收于38.62元，下跌1.48%，换手率38.79%，成交量28.78万手，成交额11.59亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出5509.54万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400028258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583468955","title":"【机构调研记录】银河基金调研盘龙药业","url":"https://stock-news.laohu8.com/highlight/detail?id=2583468955","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583468955?lang=zh_cn&edition=full","pubTime":"2025-11-14 08:05","pubTimestamp":1763078735,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月13日披露的机构调研信息，银河基金近期对1家上市公司进行了调研，相关名单如下：1）盘龙药业 调研纪要：公司以盘龙七片为主导，拥有4个独家品种及多项自主知识产权产品，涵盖12大功能类别、100多个品规。银河基金成立于2002年，截至目前，资产管理规模1080.23亿元，排名57/211；资产管理规模782.31亿元，排名55/211；管理公募基金数153只，排名50/211；旗下公募基金经理24人，排名60/211。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400005543.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777403505253,"stockEarnings":[{"period":"1week","weight":-0.0433},{"period":"1month","weight":-0.1063},{"period":"3month","weight":-0.1492},{"period":"6month","weight":-0.0074},{"period":"1year","weight":0.1239},{"period":"ytd","weight":-0.0402}],"compareEarnings":[{"period":"1week","weight":-0.0016},{"period":"1month","weight":0.0421},{"period":"3month","weight":-0.0175},{"period":"6month","weight":0.023},{"period":"1year","weight":0.2403},{"period":"ytd","weight":0.0277}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"陕西盘龙药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"22008人(较上一季度减少7.91%)","perCapita":"3348股","listingDate":"2017-11-16","address":"陕西省商洛市柞水县盘龙生态产业园","registeredCapital":"10628万元","survey":"　　陕西盘龙药业集团股份有限公司的主营业务是药材规范化种植、药品生产、研发、销售和医药物流。公司的主要产品是自产中成药、中药饮片、医药商业配送、大健康产品。公司曾荣获“国家级绿色工厂”、“CNAS实验室认证”、“全国文明单位”、ESG治理先锋等多项国家级荣誉。","listedPrice":10.03},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"盘龙药业(002864)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供盘龙药业(002864)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"盘龙药业,002864,盘龙药业股票,盘龙药业股票老虎,盘龙药业股票老虎国际,盘龙药业行情,盘龙药业股票行情,盘龙药业股价,盘龙药业股市,盘龙药业股票价格,盘龙药业股票交易,盘龙药业股票购买,盘龙药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"盘龙药业(002864)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供盘龙药业(002864)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}